Dr Ayman Al-Hendy graduated from Banha Faculty of Medicine, Zagazig University, Banha, Egypt in 1986. After 1 year of internship at Banha University Hospital, he headed to Finland to earn his PhD in Molecular Medicine from University of Turku, Turku, Finland. He then gained additional postdoctoral training in gene therapy and clinical molecular genetics at McMaster University and McGill University in Canada, before completing clinical residency training in Obstetrics and Gynecology at University of Saskatchewan and fellowship training in laparoscopic surgery at Toronto University, both in Canada.
Dr. Al-Hendy is double board certified by the Royal College of Surgeons of Canada and The American Board of Obstetrics and Gynecology. In United States of America, Dr. Al-Hendy held various faculty positions at University of Texas Medical Branch, Galveston, Texas, Meharry Medical College, Vanderbilt University, Nashville, Tennessee before moving to Augusta, Georgia where he currently is an active Gynecologist with a clinical practice focus on Treatment of Uterine Fibroids. He also holds the position of GRU Director of Interdisciplinary Translational Research, MCG Assistant Dean for Global Translational Research, Professor and Director Division of Translational Research, Department of Obstetrics and Gynecology, Georgia Regents University, Medical College of Georgia, Augusta, Georgia.
Dr. Al-Hendy utilizes the methods of basic, translational and clinical research to address important medical diseases. Dr. Al-Hendy medical research interests focus on developing novel therapies including gene and stem cell therapy for Premature Ovarian Failure, Endometriosis, and particularly Uterine Fibroids. He is currently researching the utility of various nutritional supplements as possible nonsurgical therapy for uterine fibroids which impact negatively women health worldwide and burden resources through the high rate of Hysterectomy especially in women of color. In 2010,
Dr. Al-Hendy was awarded the American Society of Reproductive Medicine’s 2010 Ira and Ester Rosenwaks Award for his significant contribution to the field of translational Reproductive Biology, and in 2014 he received the alpha Omega alpha clinician scientist of the year award by the Medical Honor Society. Dr. Al-Hendy research is continuously funded by various agency like NIH, NICHD, NCRR USDA, ODS, and other national and international organizations. He is currently serving as Chair of the NIH Integrative Clinical Endocrinology and Reproduction IRG. Dr. Al-Hendy has published more than 107 peer reviewed publications in high tier peer reviewed scientific journals, above 200 presentations in national and international meetings, and has edited 4 medical books.